Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmin B Kuemmerle-Deschner

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Seminars in Immunopathology|May 13, 2015
CAPS--pathogenesis, presentation and treatment of an autoinflammatory diseaseJasmin B Kuemmerle-Deschner
Biologics : Targets & Therapy|August 27, 2009
Abatacept in difficult-to-treat juvenile idiopathic arthritisJasmin B Kuemmerle-Deschner, Sm Benseler
Rheumatology International|July 21, 2007
Safety and efficacy of once-weekly application of Etanercept in children with juvenile idiopathic arthritisJasmin B Kuemmerle-Deschner, Gerd Horneff
Clinical Immunology (Orlando, Fla.)|May 24, 2013
Inflammasome and cytokine blocking strategies in autoinflammatory disordersMonika Moll, Jasmin B Kuemmerle-Deschner
Therapeutic Advances in Musculoskeletal Disease|December 3, 2013
Canakinumab in patients with cryopyrin-associated periodic syndrome: an update for cliniciansJasmin B Kuemmerle-Deschner, Iris Haug
Journal of Clinical Medicine|January 6, 2021
Diagnosis and Management of the Cryopyrin-Associated Periodic Syndromes (CAPS): What Do We Know Today?Tatjana Welzel, Jasmin B Kuemmerle-Deschner
Frontiers in Immunology|April 19, 2021
Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in ChildhoodTatjana Welzel, Susanne M Benseler, Jasmin B Kuemmerle-Deschner
Pediatric Rheumatology Online Journal|April 2, 2015
Dynamic knee joint function in children with juvenile idiopathic arthritis (JIA)Sandra Hansmann, Susanne M Benseler, Jasmin B Kuemmerle-Deschner
Cases Journal|February 27, 2010
Rituximab for the treatment of refractory pediatric autoimmune diseases: a case seriesNikolay Tzaribachev, Ina Koetter, Jasmin B Kuemmerle-Deschner, et al.
Journal of Clinical Medicine|January 28, 2026
Towards New Strategies: Case Report and Review of the Literature-Effective Use of JAK Inhibitor Baricitinib in a 4-Year-Old Boy with Anti-MDA5 Antibody-Positive Juvenile DermatomyositisOana Buzoianu, Özlem Satirer, Jasmin B Kuemmerle-Deschner, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Seminars in Immunopathology|May 13, 2015
CAPS--pathogenesis, presentation and treatment of an autoinflammatory diseaseJasmin B Kuemmerle-Deschner
Biologics : Targets & Therapy|August 27, 2009
Abatacept in difficult-to-treat juvenile idiopathic arthritisJasmin B Kuemmerle-Deschner, Sm Benseler
Rheumatology International|July 21, 2007
Safety and efficacy of once-weekly application of Etanercept in children with juvenile idiopathic arthritisJasmin B Kuemmerle-Deschner, Gerd Horneff
Clinical Immunology (Orlando, Fla.)|May 24, 2013
Inflammasome and cytokine blocking strategies in autoinflammatory disordersMonika Moll, Jasmin B Kuemmerle-Deschner
Therapeutic Advances in Musculoskeletal Disease|December 3, 2013
Canakinumab in patients with cryopyrin-associated periodic syndrome: an update for cliniciansJasmin B Kuemmerle-Deschner, Iris Haug
Journal of Clinical Medicine|January 6, 2021
Diagnosis and Management of the Cryopyrin-Associated Periodic Syndromes (CAPS): What Do We Know Today?Tatjana Welzel, Jasmin B Kuemmerle-Deschner
Frontiers in Immunology|April 19, 2021
Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in ChildhoodTatjana Welzel, Susanne M Benseler, Jasmin B Kuemmerle-Deschner
Pediatric Rheumatology Online Journal|April 2, 2015
Dynamic knee joint function in children with juvenile idiopathic arthritis (JIA)Sandra Hansmann, Susanne M Benseler, Jasmin B Kuemmerle-Deschner
Cases Journal|February 27, 2010
Rituximab for the treatment of refractory pediatric autoimmune diseases: a case seriesNikolay Tzaribachev, Ina Koetter, Jasmin B Kuemmerle-Deschner, et al.
Journal of Clinical Medicine|January 28, 2026
Towards New Strategies: Case Report and Review of the Literature-Effective Use of JAK Inhibitor Baricitinib in a 4-Year-Old Boy with Anti-MDA5 Antibody-Positive Juvenile DermatomyositisOana Buzoianu, Özlem Satirer, Jasmin B Kuemmerle-Deschner, et al.
Pageof 7